158 related articles for article (PubMed ID: 6750451)
1. Immunologic approaches to the diagnosis and treatment of malignant disease.
Coral FS
NITA; 1982; 5(4):256-61. PubMed ID: 6750451
[No Abstract] [Full Text] [Related]
2. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
Oka Y; Tsuboi A; Sugiyama H
Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
[No Abstract] [Full Text] [Related]
3. [1st immunologic attempts in the treatment of human malignant tumors].
Mannelli MA
Minerva Med; 1977 Apr; 68(19):1301-4. PubMed ID: 854230
[No Abstract] [Full Text] [Related]
4. Immunological approaches to the treatment of malignant disease.
Guillou PJ
J R Coll Surg Edinb; 1988 Feb; 33(1):2-8. PubMed ID: 2458468
[No Abstract] [Full Text] [Related]
5. The immune system and cancer.
Gallucci B
Oncol Nurs Forum; 1987; 14(6 Suppl):3-12. PubMed ID: 3320984
[No Abstract] [Full Text] [Related]
6. Immunologic aspects of malignancy: Factors of concern in the prospective candidate for immunotherapy.
Ablin RJ
Allergol Immunopathol (Madr); 1975; 3(2):105-8. PubMed ID: 1155313
[No Abstract] [Full Text] [Related]
7. [Progress in immunology. Therapeutic aspects in clinical medicine].
Wirth W
Med Welt; 1982 Dec; 33(51-52):1859-60. PubMed ID: 7162406
[No Abstract] [Full Text] [Related]
8. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
9. Cancer immunotherapy.
Baxevanis CN; Perez SA; Papamichail M
Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapy of malignant diseases].
Dorval T; Michon J; Tartour E; Fridman WH
Bull Cancer; 1995; 82 Suppl 2():127s-138s. PubMed ID: 7542946
[TBL] [Abstract][Full Text] [Related]
11. [Thymus hormones in the immunotherapy of malignant neoplasms (a review of the literature)].
Nikol'skiĭ IS
Vrach Delo; 1988 Aug; (8):77-82. PubMed ID: 3061171
[No Abstract] [Full Text] [Related]
12. [Immunology: new approaches to immuno-modulation and immunotherapy].
Kabelitz D
Dtsch Med Wochenschr; 2006 Jun; 131(25-26):1471-3. PubMed ID: 16794979
[No Abstract] [Full Text] [Related]
13. [Antibody and immunotherapy in oncology. Which patients benefit?].
Schlimok G
MMW Fortschr Med; 2001 Jun; 143(25):24-8. PubMed ID: 11468992
[TBL] [Abstract][Full Text] [Related]
14. [Immunotherapy for cancer--modern immunologic strategies in oncology].
Halama N; Zoernig I; Jäger D
Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy of malignant growth].
Tobiasch V
Lebensversicher Med; 1986 Sep; 38(5):133-9. PubMed ID: 2877376
[No Abstract] [Full Text] [Related]
16. [Cancer and immune defense].
Sollid LM; Thrane PS; Brandtzaeg P
Tidsskr Nor Laegeforen; 1988 May; 108(15):1205-9. PubMed ID: 3291190
[No Abstract] [Full Text] [Related]
17. Cancer immunotherapy.
Schuster M; Nechansky A; Kircheis R
Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
[TBL] [Abstract][Full Text] [Related]
18. [Cancer and immunity].
Cerottini JC; Mach JP
Rev Med Suisse Romande; 1974 Sep; 94(9):675-84. PubMed ID: 4438877
[No Abstract] [Full Text] [Related]
19. Immune monitoring of cancer patients undergoing experimental immunotherapy.
Shankar G; Salgaller ML
Curr Opin Mol Ther; 2000 Feb; 2(1):66-73. PubMed ID: 11249653
[TBL] [Abstract][Full Text] [Related]
20. Summary of the conference on immunology of carcinogensis.
Baker CG
Natl Cancer Inst Monogr; 1972 Dec; 35():445-60. PubMed ID: 4572835
[No Abstract] [Full Text] [Related]
[Next] [New Search]
